Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Janssen CAR T deal supports Elicera’s vision

The 245 million USD deal between Janssen and Cellular Biomedicine Group to develop next generation CAR T therapies signals a strong willingness to invest in the field. The deal raises commercial hopes for other players in the CAR T space. One of these is Elicera Therapeutics, whose candidate, ELC-301, also targets the CD20 antigen for the treatment of Non-Hodgkin's Lymphoma.Read the article at biostock.se: Janssen CAR T deal supports Elicera’s vision - BioStock This is a press release from BioStock -

2020 Bulkers Ltd. (2020) – Commercial update and key information relating to the cash distribution for April 2023

Oslo, Norway, May 10, 2023 Commercial update: In April 2023, the Company achieved average time charter equivalent earnings of approximately US$24,400 per day, gross. The Company’s five vessels trading on index-linked time charter earned approximately US$26,100 per day, gross, including average daily scrubber benefits of approximately US$4,100 per day. The Company’s three vessels trading on fixed time charter earned approximately US$21,600 per day, gross, including scrubber benefits. The Baltic 5TC Capesize Index averaged US$15,931 during April 2023. Cash Distribution: The

Invitation to presentation of Catena Media’s Q1 results 2023

Catena Media’s interim report for the first quarter that ended 31 March 2023 will be published in English on Wednesday 17 May at 07:00 CEST. Following the report’s release, a combined presentation audiocast and telephone conference with the opportunity to ask questions will be held at 09:00 CEST on the same day, with CEO Michael Daly and Group CFO Peter Messner presenting the report. WebcastVia the webcast you are able to ask written questions. If you wish to participate via webcast, please use the following link: https://ir.financialhearings.com/catena-media-q1-2023

UNION therapeutics to present at 4th Annual Dermatology Drug Development Summit Europe

Hellerup, Denmark, May 10, 2023 – UNION therapeutics A/S (UNION), a privately held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, today announced that Dr. Kim D. Kjøller, CEO of UNION therapeutics will present at the seminar on hidradenitis suppurativa (HS) at the 4th Annual Dermatology Drug Development Summit Europe on May 22-24, 2023, in Berlin, Germany. Dr. Kjøller will discuss the current HS landscape incl. learnings on new ways to develop better treatments across dermatology and immunology.   Dr. Kjøller will also be

Sales of Kemppi welding gloves started

KEMPPI     PRESS RELEASE     10 MAY 2023     09.00 EET Sales of Kemppi welding gloves started Kemppi welding gloves, now available for ordering, keep welding hands safe. Kemppi welding gloves have been developed with Kemppi’s uncompromising design integrity and safety standards, with high-quality materials for excellent functionality. Welding gloves fulfills Kemppi’s safety offering. “It simply felt like a logical next step in our product development – since we know welding, we had a good sense of what is required from a pair of truly great welding gloves,” says Roger Rasmussen,

Interim report

January 1 – March 31, 2022The first quarter in figures · Net sales were TSEK 5,149 (4,260), +21%. · The loss after tax was TSEK 10,906 (9,736). · The loss per share was SEK 0.15 (0.14). · The cash flow from current operations was negative in the amount of TSEK 3,751 (10,512). · The gross margin was 68.7% (62.8%). · Electrode sales volume increased by 16% and were 11,614 (9,982) units. Repeat sales of electrodes to existing customers increased by 11%. Important events during the quarter · Overall sales increased by 21% (+13%, before currency effects). Sales in the

Photocure ASA: Results for the first quarter of 2023

Oslo, Norway, 10 May 2023 - Photocure ASA (OSE:PHO) today reported Hexvix[®]/Cysview[®] revenues of NOK 105.9 million in the first quarter of 2023 (Q1 2022: NOK 81.4 million) and EBITDA of minus NOK 1.2 million (NOK -13.9 million). Total revenues increased 30% year over year, and 30 high-definition blue light towers were installed in the first quarter (18 new and 12 upgrades). Photocure reiterates its guidance for 2023 and expects to deliver new Saphira™ blue light tower installations in the U.S. in the range of 65 to 75, consolidated product revenue growth above 20%, and positive EBITDA

Nordic Mining ASA (EN Expand:NOM): Interim report per 31 March 2023

Please find enclosed Nordic Mining’s interim report and company presentation for the first quarter of 2023. The interim report and company updates will be presented digitally today, Wednesday 10 May 2023 at 10.00 (CET). The presentation and Q&A session will be held in English and transferred via webcast. You will have the opportunity to post questions online throughout the webcast session. The webcast will be available on: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230510_6 Summary of important events in the first quarter of 2023 and year to date: KEY EVENTS ·

2020 Bulkers Ltd. (2020) - Results for the first quarter of 2023

Oslo, Norway, May 10, 2023 2020 Bulkers Ltd. (“2020 Bulkers” or the “Company”), today announced its unaudited financial and operating results for the three months ended March 31, 2023. Key events during the first quarter of 2023 · The Company reported net profit of US$0.8 million and EBITDA of US$6.4 million for the first quarter of 2023. · Achieved average time charter equivalent earnings of approximately US$17,500 per day, gross. · The Company declared total cash distributions of US$0.04 per share for the months of January, February and March 2023. · In January

MTG concludes SEK 377 million share buy-back program

Modern Times Group MTG AB (publ) (“MTG”) has today successfully concluded the share repurchase program launched in October 2022, which has enabled MTG to buy back 4,618,588 own class B shares for approximately SEK 377,4 million, at a volume-weighted average price of SEK 81.7145 per share. This initiative is part of MTG’s ongoing efforts to optimize its capital structure and deliver shareholder value.MTG has created significant shareholder returns since the divestment of ESL Gaming in April 2022. This has been achieved through a cash transfer of SEK 25 per share through MTG’s SEK 2.8 billion

FlexQubes report for the first quarter 2023

FIRST QUARTER 2023 · Order intake decreased by 25.6 percent to 35.7 MSEK (48.0). Adjusted for foreign exchange rate effects between the comparison periods, order intake decreased by 34.6 percent.  · Net sales decreased by 32.5 percent to 29.4 MSEK (43.5). Adjusted for foreign exchange rate effects between the comparison periods, net sales decreased by 37.0 percent. · Operating profit before depreciation (EBITDA) amounted to -11.9 MSEK (-4.8) and operating profit before financial items (EBIT) amounted to -13.3 MSEK (-6.0). · Profit before tax amounted to -13.7 MSEK (-6.1). ·

Orthex’s Q1 Interim Report and invitation to the result presentation on 17 May 2023

Orthex Corporation, Press release, 10 May 2023 at 9.00 a.m. EESTOrthex will publish its Interim Report for the period January−March 2023 on Wednesday, 17 May 2023 at around 9.00 a.m. EEST. Following the publication, the report will be available in pdf-format on the corporate website https://investors.orthexgroup.com/.Orthex’s CEO Alexander Rosenlew, CFO Saara Mäkelä and CMO Hanna Kukkonen will present the interim report on the same day at 11.00 a.m. EEST in a webcast. The webcast can be joined through this link . The webcast presentation

Polymer Factory Sweden AB (publ) Interim Report Q1 2023

The period in summary First quarter, January-March 2023 · Net sales increased with close to 40% compared to the same period 2022 · The Board of Directors resolved on a share issue, with subsequent approval by the EGM · The Company raised approx. SEK 6,1 million* through a rights issue of shares · The first instalment of the EDF grant was paid, amounting to approx. SEK 1,8 million *before deduction of transaction related costs Key Figures (KSEK) Jan-Mar Jan-Mar 2023 2022Net sales

First six months 2023: Order Intake Doubles To More Than €10 Million

TIE Kinetix announces its interim financial results for the first half year of FY 2023 today.TIE Kinetix , a leader in 100% supply chain digitalization, announces its interim financial results for the first half year of FY 2023 today.  Read the full press release in attached PDF. This document may contain expectations about the financial state of affairs and results of the activities of TIE Kinetix as well as certain related plans and objectives, and may be expressed in a variety of ways, such as ‘expects’, ‘projects’, ‘anticipates’

Skanska invests a net of NOK 318M, about SEK 320M, in residential projects with OBOS in Oslo and Bærum, Norway

Skanska and OBOS has signed a contract for two joint venture projects in Oslo and Bærum, Norway, to develop and build approximately 700 homes together during the next years. Skanska invests NOK 525M, about SEK 530M to acquire 50 percent of OBOS’s project Nansenløkka and divests 50 percent of the project Økern Park for NOK 207M, about SEK 210M, to OBOS.Nansenløkka on Fornebu in Bærum will consist of approximately 400 units and the expected start of construction is the last quarter of 2023. Økern Park on Økern in Oslo is planned for approximately 300 units and the expected start of

Raute receives order of EUR 44.6 million to France

RAUTE CORPORATION PRESS RELEASE May 10, 2023 at 09:00 a.m. Raute receives order of EUR 44.6 million to France Raute Corporation has signed a contract worth EUR 44.6 million with the THEBAULT Group, France for the technology delivery of a new greenfield LVL (Laminated Veneer Lumber) production plant. Following the terms of the contract, the project has become effective by the signing of a delivery contract. This project was earlier referred to in the stock exchange release dated March 9, 2023 (Raute plans directed share issue, rights issue, and junior loan support targeted growth

Vestas – Interim Financial Report, First Quarter 2023

Summary: Quarterly revenue of EUR 2.8bn with an EBIT margin before special items of 1.4 percent. Continued strong wind turbine backlog of EUR 19.7bn driven by higher order intake. Full-year guidance maintained. In the first quarter of 2023, Vestas generated revenue of EUR 2,829m – an increase of 14 percent compared to the year-earlier period. EBIT before special items amounted to EUR 40m, resulting in an EBIT margin before special items of 1.4 percent, compared to negative 13.2 percent in the first quarter of 2022. Free cash flow[1)] amounted to negative EUR 1,081m compared to

HC Andersen Capital Events 10/05: Meet the top management in BioPorto

HC Andersen Capital is hosting a digital event where you can meet and ask questions directly to the top management. It is free for all to attend.BioPorto - Presentation of Q1 2023BioPorto releases its Interim Report for the first quarter of 2023 on Wednesday, May 10th, and participates in a digital event hosted by HC Andersen Capital at 14:30 CEST where CEO Tony Paré and CFO Neil Goldman will present the report and highlights from the first quarter period followed by a Q&A session.  Disclaimer: HC Andersen Capital receives payment from BioPorto for a Digital IR/Corporate Visibility

Interim report Q1: Clear effects of cost reductions and positive cash flow but generally lower market activity hits the volumes

January-March 2023 • Net sales amounted to SEK 246 million (237). Net sales declined 4 percent organically. • The EVSE share of net sales increased to 39 percent (17) and amounted to SEK 96 million (37). • Adjusted EBITA declined to SEK 7 million (22), corresponding to amargin of 3.0 percent (9.3). • Net profit for the period amounted to SEK -18 million (profit: 11) and earnings per share after dilution amounted to SEK -0.35 (0.22). • Cash flow from operating activities amounted to SEK 36 million (-1). • CTEK carried out a rights issue of 350 SEK million in March that was

Storebrand Boligkreditt AS: Interim Report Q1 2023

Storebrand Boligkreditt AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2023 result and Balance sheet statement, please refer to the Storebrand Group Q1 2023 interim report. Storebrand Boligkreditt AS's interim report for Q1 2023 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Storebrand Livsforsikring AS: Interim Report Q1 2023

Storebrand Livsforsikring AS is a wholly owned subsidiary of the listed company Storebrand ASA. For information about the Storebrand Group's Q1 2023 result and Balance sheet statement, please refer to the Storebrand Group Q1 2023 interim report. Storebrand Livsforsikring AS's interim report for Q1 2023 is attached.This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)

Lundbeck’s sales increased by 15% (+11% at constant exchange rates) to DKK 5 billion in the first quarter of 2023

Key highlights Lundbeck’s sales increased by 15% (+11% CER[1]) to DKK 5,044 million, with all regions growing and the U.S. and Europe contributing strongly · United States: DKK 2,337 million (+22%; +16% CER) · International Markets: DKK 1,499 million (+3%; +3% CER) · Europe: DKK 1,174 million (+15%; +14% CER) The growth of Lundbeck’s strategic brands grew further with an increase of 23% (+19% CER), reaching DKK 3,273 million, representing 65% of total revenue · Brintellix[®]/Trintellix[®]: DKK 1,077 million (+9%; +7% CER) · Rexulti[®]/Rxulti[®]: DKK 1,060 million (

HKScan’s profitability improved, but January-March EBIT slightly negative

HKScan Corporation, January-March Interim Report, 10 May 2023 at 8.30 a.m. EETHKScan’s Interim Report 1 January – 31 March 2023 January-March 2023  · HKScan’s net sales from continuing operations increased by 15.6 per cent to EUR 457.6 (395.9) million. During the review period, sales prices were significantly higher than in the comparison period as higher costs due to strong inflation had been passed on to sales prices during 2022. · The Group’s EBIT from continuing operations totalled EUR -0.1 (-4.4) million.  · The Group’s comparable EBIT from continuing operations was EUR -

There are no items matching the current filter
There are no more items matching the current filter
Back to top